Research is being conducted on the effects of stopping GLP-1 drugs, with some studies suggesting that cardiovascular benefits may be quickly lost. The transition off these medications can be a topic of uncertainty for users, with some reports indicating that stopping and restarting the drugs may reduce their effectiveness for weight loss. The impact of stopping GLP-1 drugs is being explored by various medical institutions, including the Cleveland Clinic, which has released a study on the subject.